NEWLY DIAGNOSED
Clinical trials for NEWLY DIAGNOSED explained in plain language.
Never miss a new study
Get alerted when new NEWLY DIAGNOSED trials appear
Sign up with your email to follow new studies for NEWLY DIAGNOSED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for older AML patients: four-drug combos tested in phase 2 trial
Disease control Recruiting nowThis study compares four different drug combinations for adults newly diagnosed with acute myeloid leukemia (AML) who are not healthy enough for strong chemotherapy or choose not to have it. About 172 participants will be randomly assigned to one of four groups to see which combi…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 26, 2026 09:50 UTC
-
New drug MP0533 tested in leukemia patients – could it control the disease?
Disease control Recruiting nowThis study is testing a new drug, MP0533, in about 249 adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has come back or not responded to treatment. The goal is to find the safest dose and see if the drug can help control the cancer. Participants wi…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE1, PHASE2 • Sponsor: Molecular Partners AG • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Could a liver pill boost chemo for leukemia?
Disease control Recruiting nowThis study tests whether adding silibinin (a liver-protecting supplement) to standard chemotherapy can improve outcomes for people newly diagnosed with acute myeloid leukemia (AML). About 100 adults will be randomly assigned to receive chemo with or without silibinin. The goal is…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE4 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New hope for leukemia patients too frail for chemo?
Disease control Recruiting nowThis study tests a combination of three drugs (venetoclax, azacytidine, and chidamide) for people newly diagnosed with a specific type of leukemia called acute monocytic leukemia who are not healthy enough for standard intensive chemotherapy. The goal is to see if this drug combo…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
Blood cancer study seeks to uncover hidden barriers to Life-Saving transplants
Knowledge-focused Recruiting nowThis study tracks over 1,300 people with blood cancers like acute leukemia to see how many receive a stem cell transplant and why some do not. Researchers want to understand the medical and personal reasons behind these decisions. The goal is to identify barriers so more patients…
Matched conditions: NEWLY DIAGNOSED
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC